FULGENT GENETICS, INC. (FLGT) Free cash flow 2016–2025
FULGENT GENETICS, INC. (FLGT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$124.2MFY2025 · since FY2016: $617,000 → -$124.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$124.2M | -545.1% |
| FY2024 | -$19.3M | -501.5% |
| FY2023 | $4.8M | -98.0% |
| FY2022 | $234.7M | -54.4% |
| FY2021 | $514.8M | +387.9% |
| FY2020 | $105.5M | +2333.6% |
| FY2019 | $4.3M | +244.6% |
| FY2018 | -$3.0M | -91.6% |
| FY2017 | -$1.6M | -353.5% |
| FY2016 | $617,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More FLGT financial trends
FLGT RevenueFLGT Net incomeFLGT Net marginFLGT Gross profitFLGT Gross marginFLGT Operating incomeFLGT Operating marginFLGT Operating cash flowFLGT Capital expendituresFLGT Return on equityFLGT Stock buybacksFLGT Dividends paidFLGT Total assetsFLGT Total liabilitiesFLGT Shareholders’ equityFLGT overview →